Stock Screener App
Free
-
Play Store
App Store
Install
Install
Dark
EN
Sign in
Watchlist
Top Lists
Markets
New
Options
Cryptos
Industries
Elite
Market Simulator
SABS
$2.95
0.34%
0.01
Sab Biotherapeutics Inc (SABS)
Indicator
5
EX
1min
5min
Hourly
Daily
Weekly
Monthly
Line
Candle
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Similar to SABS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Sab Biotherapeutics Inc Stock (SABS) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Period Length
3 Months
3 Months
3 Months
3 Months
3 Months
Operating Expenses
16.90%
23.38
20.00
15.77
12.68
9.73
Research and Development
20.70%
16.17
13.40
10.73
8.97
7.00
Operating Income/Loss
16.90%
-23.38
-20.00
-15.77
-12.68
-9.73
Nonoperating Income/Loss
21.51%
0.89
1.13
-1.09
58.12
-0.38
Net Income/Loss
19.20%
-22.49
-18.87
-16.86
45.45
-10.11
Attributable To Parent
19.20%
-22.49
-18.87
-16.86
45.45
-10.11
Available To Common Stockholders, Basic
19.20%
-22.49
-18.87
-2.85
5.34
-10.11
Basic Average Shares
48.91%
79.75
53.56
9.56
10.66
9.29
Diluted Average Shares
48.91%
79.75
53.56
31.04
77.86
9.29
Basic Earnings Per Share
20.00%
-0.28
-0.35
-0.51
0.50
-1.09
Diluted Earnings Per Share
20.00%
-0.28
-0.35
-0.46
-0.21
-1.09
